Global Nucleic Acid Multiplex Assay Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nucleic Acid Multiplex Assay market size was valued at US$ million in 2023. With growing demand in downstream market, the Nucleic Acid Multiplex Assay is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nucleic Acid Multiplex Assay market. Nucleic Acid Multiplex Assay are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid Multiplex Assay. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid Multiplex Assay market.
Key Features:
The report on Nucleic Acid Multiplex Assay market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid Multiplex Assay market. It may include historical data, market segmentation by Type (e.g., Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid Multiplex Assay market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid Multiplex Assay market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid Multiplex Assay industry. This include advancements in Nucleic Acid Multiplex Assay technology, Nucleic Acid Multiplex Assay new entrants, Nucleic Acid Multiplex Assay new investment, and other innovations that are shaping the future of Nucleic Acid Multiplex Assay.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid Multiplex Assay market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid Multiplex Assay product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid Multiplex Assay market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid Multiplex Assay market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid Multiplex Assay market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid Multiplex Assay industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid Multiplex Assay market.
Market Segmentation:
Nucleic Acid Multiplex Assay market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Nucleic Acid Multiplex Assay market size was valued at US$ million in 2023. With growing demand in downstream market, the Nucleic Acid Multiplex Assay is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Nucleic Acid Multiplex Assay market. Nucleic Acid Multiplex Assay are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid Multiplex Assay. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid Multiplex Assay market.
Key Features:
The report on Nucleic Acid Multiplex Assay market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid Multiplex Assay market. It may include historical data, market segmentation by Type (e.g., Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid Multiplex Assay market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid Multiplex Assay market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid Multiplex Assay industry. This include advancements in Nucleic Acid Multiplex Assay technology, Nucleic Acid Multiplex Assay new entrants, Nucleic Acid Multiplex Assay new investment, and other innovations that are shaping the future of Nucleic Acid Multiplex Assay.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid Multiplex Assay market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid Multiplex Assay product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid Multiplex Assay market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid Multiplex Assay market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid Multiplex Assay market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid Multiplex Assay industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid Multiplex Assay market.
Market Segmentation:
Nucleic Acid Multiplex Assay market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Planar Nucleic Acid Assays
- Bead-Based Nucleic Acid Assays
- Other Nucleic Acid Assays
- Pharmaceutical & Biotechnology Companies
- Hospitals & Research Institutes
- Reference Laboratories
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Luminex Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- Illumina, Inc (US)
- Bio-Rad Laboratories, Inc. (US)
- Qiagen N.V. (Netherlands)
- Abcam plc (UK)
- Becton, Dickinson and Company (US)
- Merck KGaA (Germany)
- Agilent Technologies, Inc. (US)
- Meso Scale Diagnostics (US)
- Randox Laboratories (UK)
- Quanterix (US)
- Bio-Techne Corporation (US)
- Olink (Sweden)
- DiaSorin S.p.A. (Italy)
- Seegene (South Korea)
- Promega Corporation (US)
- Siemens Healthineers (Germany)
- PerkinElmer, Inc. (US)
- Shimadzu Biotech (Japan)
- Antigenix America, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Boster Biological Technology (US)
- AYOXXA Biosystems GmbH (Germany)
- Cayman Chemical Company (US)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Multiplex Assay Market Size 2019-2030
2.1.2 Nucleic Acid Multiplex Assay Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nucleic Acid Multiplex Assay Segment by Type
2.2.1 Planar Nucleic Acid Assays
2.2.2 Bead-Based Nucleic Acid Assays
2.2.3 Other Nucleic Acid Assays
2.3 Nucleic Acid Multiplex Assay Market Size by Type
2.3.1 Nucleic Acid Multiplex Assay Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid Multiplex Assay Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Hospitals & Research Institutes
2.4.3 Reference Laboratories
2.4.4 Other
2.5 Nucleic Acid Multiplex Assay Market Size by Application
2.5.1 Nucleic Acid Multiplex Assay Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID MULTIPLEX ASSAY MARKET SIZE BY PLAYER
3.1 Nucleic Acid Multiplex Assay Market Size Market Share by Players
3.1.1 Global Nucleic Acid Multiplex Assay Revenue by Players (2019-2024)
3.1.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid Multiplex Assay Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID MULTIPLEX ASSAY BY REGIONS
4.1 Nucleic Acid Multiplex Assay Market Size by Regions (2019-2024)
4.2 Americas Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.3 APAC Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.4 Europe Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.5 Middle East & Africa Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid Multiplex Assay Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Multiplex Assay Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Multiplex Assay by Country (2019-2024)
7.2 Europe Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Multiplex Assay by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID MULTIPLEX ASSAY MARKET FORECAST
10.1 Global Nucleic Acid Multiplex Assay Forecast by Regions (2025-2030)
10.1.1 Global Nucleic Acid Multiplex Assay Forecast by Regions (2025-2030)
10.1.2 Americas Nucleic Acid Multiplex Assay Forecast
10.1.3 APAC Nucleic Acid Multiplex Assay Forecast
10.1.4 Europe Nucleic Acid Multiplex Assay Forecast
10.1.5 Middle East & Africa Nucleic Acid Multiplex Assay Forecast
10.2 Americas Nucleic Acid Multiplex Assay Forecast by Country (2025-2030)
10.2.1 United States Nucleic Acid Multiplex Assay Market Forecast
10.2.2 Canada Nucleic Acid Multiplex Assay Market Forecast
10.2.3 Mexico Nucleic Acid Multiplex Assay Market Forecast
10.2.4 Brazil Nucleic Acid Multiplex Assay Market Forecast
10.3 APAC Nucleic Acid Multiplex Assay Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid Multiplex Assay Market Forecast
10.3.2 Japan Nucleic Acid Multiplex Assay Market Forecast
10.3.3 Korea Nucleic Acid Multiplex Assay Market Forecast
10.3.4 Southeast Asia Nucleic Acid Multiplex Assay Market Forecast
10.3.5 India Nucleic Acid Multiplex Assay Market Forecast
10.3.6 Australia Nucleic Acid Multiplex Assay Market Forecast
10.4 Europe Nucleic Acid Multiplex Assay Forecast by Country (2025-2030)
10.4.1 Germany Nucleic Acid Multiplex Assay Market Forecast
10.4.2 France Nucleic Acid Multiplex Assay Market Forecast
10.4.3 UK Nucleic Acid Multiplex Assay Market Forecast
10.4.4 Italy Nucleic Acid Multiplex Assay Market Forecast
10.4.5 Russia Nucleic Acid Multiplex Assay Market Forecast
10.5 Middle East & Africa Nucleic Acid Multiplex Assay Forecast by Region (2025-2030)
10.5.1 Egypt Nucleic Acid Multiplex Assay Market Forecast
10.5.2 South Africa Nucleic Acid Multiplex Assay Market Forecast
10.5.3 Israel Nucleic Acid Multiplex Assay Market Forecast
10.5.4 Turkey Nucleic Acid Multiplex Assay Market Forecast
10.5.5 GCC Countries Nucleic Acid Multiplex Assay Market Forecast
10.6 Global Nucleic Acid Multiplex Assay Forecast by Type (2025-2030)
10.7 Global Nucleic Acid Multiplex Assay Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Information
11.1.2 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Luminex Corporation (US) Main Business Overview
11.1.5 Luminex Corporation (US) Latest Developments
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Information
11.2.2 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. (US) Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. (US) Latest Developments
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Information
11.3.2 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Offered
11.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina, Inc (US) Main Business Overview
11.3.5 Illumina, Inc (US) Latest Developments
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Information
11.4.2 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bio-Rad Laboratories, Inc. (US) Main Business Overview
11.4.5 Bio-Rad Laboratories, Inc. (US) Latest Developments
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Information
11.5.2 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Offered
11.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Qiagen N.V. (Netherlands) Main Business Overview
11.5.5 Qiagen N.V. (Netherlands) Latest Developments
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Information
11.6.2 Abcam plc (UK) Nucleic Acid Multiplex Assay Product Offered
11.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abcam plc (UK) Main Business Overview
11.6.5 Abcam plc (UK) Latest Developments
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Information
11.7.2 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Offered
11.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Becton, Dickinson and Company (US) Main Business Overview
11.7.5 Becton, Dickinson and Company (US) Latest Developments
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Information
11.8.2 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Offered
11.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck KGaA (Germany) Main Business Overview
11.8.5 Merck KGaA (Germany) Latest Developments
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Information
11.9.2 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Agilent Technologies, Inc. (US) Main Business Overview
11.9.5 Agilent Technologies, Inc. (US) Latest Developments
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Information
11.10.2 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Offered
11.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Meso Scale Diagnostics (US) Main Business Overview
11.10.5 Meso Scale Diagnostics (US) Latest Developments
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Information
11.11.2 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Offered
11.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Randox Laboratories (UK) Main Business Overview
11.11.5 Randox Laboratories (UK) Latest Developments
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Information
11.12.2 Quanterix (US) Nucleic Acid Multiplex Assay Product Offered
11.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Quanterix (US) Main Business Overview
11.12.5 Quanterix (US) Latest Developments
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Information
11.13.2 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bio-Techne Corporation (US) Main Business Overview
11.13.5 Bio-Techne Corporation (US) Latest Developments
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Information
11.14.2 Olink (Sweden) Nucleic Acid Multiplex Assay Product Offered
11.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Olink (Sweden) Main Business Overview
11.14.5 Olink (Sweden) Latest Developments
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Information
11.15.2 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Offered
11.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 DiaSorin S.p.A. (Italy) Main Business Overview
11.15.5 DiaSorin S.p.A. (Italy) Latest Developments
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Information
11.16.2 Seegene (South Korea) Nucleic Acid Multiplex Assay Product Offered
11.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Seegene (South Korea) Main Business Overview
11.16.5 Seegene (South Korea) Latest Developments
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Information
11.17.2 Promega Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Promega Corporation (US) Main Business Overview
11.17.5 Promega Corporation (US) Latest Developments
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Information
11.18.2 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Offered
11.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Siemens Healthineers (Germany) Main Business Overview
11.18.5 Siemens Healthineers (Germany) Latest Developments
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Information
11.19.2 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 PerkinElmer, Inc. (US) Main Business Overview
11.19.5 PerkinElmer, Inc. (US) Latest Developments
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Information
11.20.2 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Offered
11.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Shimadzu Biotech (Japan) Main Business Overview
11.20.5 Shimadzu Biotech (Japan) Latest Developments
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Information
11.21.2 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Antigenix America, Inc. (US) Main Business Overview
11.21.5 Antigenix America, Inc. (US) Latest Developments
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Information
11.22.2 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Enzo Life Sciences, Inc. (US) Main Business Overview
11.22.5 Enzo Life Sciences, Inc. (US) Latest Developments
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Information
11.23.2 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Offered
11.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Boster Biological Technology (US) Main Business Overview
11.23.5 Boster Biological Technology (US) Latest Developments
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Information
11.24.2 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Offered
11.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 AYOXXA Biosystems GmbH (Germany) Main Business Overview
11.24.5 AYOXXA Biosystems GmbH (Germany) Latest Developments
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Information
11.25.2 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Offered
11.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Cayman Chemical Company (US) Main Business Overview
11.25.5 Cayman Chemical Company (US) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Multiplex Assay Market Size 2019-2030
2.1.2 Nucleic Acid Multiplex Assay Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nucleic Acid Multiplex Assay Segment by Type
2.2.1 Planar Nucleic Acid Assays
2.2.2 Bead-Based Nucleic Acid Assays
2.2.3 Other Nucleic Acid Assays
2.3 Nucleic Acid Multiplex Assay Market Size by Type
2.3.1 Nucleic Acid Multiplex Assay Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid Multiplex Assay Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Hospitals & Research Institutes
2.4.3 Reference Laboratories
2.4.4 Other
2.5 Nucleic Acid Multiplex Assay Market Size by Application
2.5.1 Nucleic Acid Multiplex Assay Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
3 NUCLEIC ACID MULTIPLEX ASSAY MARKET SIZE BY PLAYER
3.1 Nucleic Acid Multiplex Assay Market Size Market Share by Players
3.1.1 Global Nucleic Acid Multiplex Assay Revenue by Players (2019-2024)
3.1.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid Multiplex Assay Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID MULTIPLEX ASSAY BY REGIONS
4.1 Nucleic Acid Multiplex Assay Market Size by Regions (2019-2024)
4.2 Americas Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.3 APAC Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.4 Europe Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
4.5 Middle East & Africa Nucleic Acid Multiplex Assay Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nucleic Acid Multiplex Assay Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Multiplex Assay Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Multiplex Assay by Country (2019-2024)
7.2 Europe Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Multiplex Assay by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID MULTIPLEX ASSAY MARKET FORECAST
10.1 Global Nucleic Acid Multiplex Assay Forecast by Regions (2025-2030)
10.1.1 Global Nucleic Acid Multiplex Assay Forecast by Regions (2025-2030)
10.1.2 Americas Nucleic Acid Multiplex Assay Forecast
10.1.3 APAC Nucleic Acid Multiplex Assay Forecast
10.1.4 Europe Nucleic Acid Multiplex Assay Forecast
10.1.5 Middle East & Africa Nucleic Acid Multiplex Assay Forecast
10.2 Americas Nucleic Acid Multiplex Assay Forecast by Country (2025-2030)
10.2.1 United States Nucleic Acid Multiplex Assay Market Forecast
10.2.2 Canada Nucleic Acid Multiplex Assay Market Forecast
10.2.3 Mexico Nucleic Acid Multiplex Assay Market Forecast
10.2.4 Brazil Nucleic Acid Multiplex Assay Market Forecast
10.3 APAC Nucleic Acid Multiplex Assay Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid Multiplex Assay Market Forecast
10.3.2 Japan Nucleic Acid Multiplex Assay Market Forecast
10.3.3 Korea Nucleic Acid Multiplex Assay Market Forecast
10.3.4 Southeast Asia Nucleic Acid Multiplex Assay Market Forecast
10.3.5 India Nucleic Acid Multiplex Assay Market Forecast
10.3.6 Australia Nucleic Acid Multiplex Assay Market Forecast
10.4 Europe Nucleic Acid Multiplex Assay Forecast by Country (2025-2030)
10.4.1 Germany Nucleic Acid Multiplex Assay Market Forecast
10.4.2 France Nucleic Acid Multiplex Assay Market Forecast
10.4.3 UK Nucleic Acid Multiplex Assay Market Forecast
10.4.4 Italy Nucleic Acid Multiplex Assay Market Forecast
10.4.5 Russia Nucleic Acid Multiplex Assay Market Forecast
10.5 Middle East & Africa Nucleic Acid Multiplex Assay Forecast by Region (2025-2030)
10.5.1 Egypt Nucleic Acid Multiplex Assay Market Forecast
10.5.2 South Africa Nucleic Acid Multiplex Assay Market Forecast
10.5.3 Israel Nucleic Acid Multiplex Assay Market Forecast
10.5.4 Turkey Nucleic Acid Multiplex Assay Market Forecast
10.5.5 GCC Countries Nucleic Acid Multiplex Assay Market Forecast
10.6 Global Nucleic Acid Multiplex Assay Forecast by Type (2025-2030)
10.7 Global Nucleic Acid Multiplex Assay Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Information
11.1.2 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Luminex Corporation (US) Main Business Overview
11.1.5 Luminex Corporation (US) Latest Developments
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Information
11.2.2 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Inc. (US) Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. (US) Latest Developments
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Information
11.3.2 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Offered
11.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina, Inc (US) Main Business Overview
11.3.5 Illumina, Inc (US) Latest Developments
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Information
11.4.2 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bio-Rad Laboratories, Inc. (US) Main Business Overview
11.4.5 Bio-Rad Laboratories, Inc. (US) Latest Developments
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Information
11.5.2 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Offered
11.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Qiagen N.V. (Netherlands) Main Business Overview
11.5.5 Qiagen N.V. (Netherlands) Latest Developments
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Information
11.6.2 Abcam plc (UK) Nucleic Acid Multiplex Assay Product Offered
11.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abcam plc (UK) Main Business Overview
11.6.5 Abcam plc (UK) Latest Developments
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Information
11.7.2 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Offered
11.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Becton, Dickinson and Company (US) Main Business Overview
11.7.5 Becton, Dickinson and Company (US) Latest Developments
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Information
11.8.2 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Offered
11.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck KGaA (Germany) Main Business Overview
11.8.5 Merck KGaA (Germany) Latest Developments
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Information
11.9.2 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Agilent Technologies, Inc. (US) Main Business Overview
11.9.5 Agilent Technologies, Inc. (US) Latest Developments
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Information
11.10.2 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Offered
11.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Meso Scale Diagnostics (US) Main Business Overview
11.10.5 Meso Scale Diagnostics (US) Latest Developments
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Information
11.11.2 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Offered
11.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Randox Laboratories (UK) Main Business Overview
11.11.5 Randox Laboratories (UK) Latest Developments
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Information
11.12.2 Quanterix (US) Nucleic Acid Multiplex Assay Product Offered
11.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Quanterix (US) Main Business Overview
11.12.5 Quanterix (US) Latest Developments
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Information
11.13.2 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Bio-Techne Corporation (US) Main Business Overview
11.13.5 Bio-Techne Corporation (US) Latest Developments
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Information
11.14.2 Olink (Sweden) Nucleic Acid Multiplex Assay Product Offered
11.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Olink (Sweden) Main Business Overview
11.14.5 Olink (Sweden) Latest Developments
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Information
11.15.2 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Offered
11.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 DiaSorin S.p.A. (Italy) Main Business Overview
11.15.5 DiaSorin S.p.A. (Italy) Latest Developments
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Information
11.16.2 Seegene (South Korea) Nucleic Acid Multiplex Assay Product Offered
11.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Seegene (South Korea) Main Business Overview
11.16.5 Seegene (South Korea) Latest Developments
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Information
11.17.2 Promega Corporation (US) Nucleic Acid Multiplex Assay Product Offered
11.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Promega Corporation (US) Main Business Overview
11.17.5 Promega Corporation (US) Latest Developments
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Information
11.18.2 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Offered
11.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Siemens Healthineers (Germany) Main Business Overview
11.18.5 Siemens Healthineers (Germany) Latest Developments
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Information
11.19.2 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 PerkinElmer, Inc. (US) Main Business Overview
11.19.5 PerkinElmer, Inc. (US) Latest Developments
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Information
11.20.2 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Offered
11.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Shimadzu Biotech (Japan) Main Business Overview
11.20.5 Shimadzu Biotech (Japan) Latest Developments
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Information
11.21.2 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Antigenix America, Inc. (US) Main Business Overview
11.21.5 Antigenix America, Inc. (US) Latest Developments
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Information
11.22.2 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
11.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Enzo Life Sciences, Inc. (US) Main Business Overview
11.22.5 Enzo Life Sciences, Inc. (US) Latest Developments
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Information
11.23.2 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Offered
11.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Boster Biological Technology (US) Main Business Overview
11.23.5 Boster Biological Technology (US) Latest Developments
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Information
11.24.2 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Offered
11.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 AYOXXA Biosystems GmbH (Germany) Main Business Overview
11.24.5 AYOXXA Biosystems GmbH (Germany) Latest Developments
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Information
11.25.2 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Offered
11.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Cayman Chemical Company (US) Main Business Overview
11.25.5 Cayman Chemical Company (US) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid Multiplex Assay Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Planar Nucleic Acid Assays
Table 3. Major Players of Bead-Based Nucleic Acid Assays
Table 4. Major Players of Other Nucleic Acid Assays
Table 5. Nucleic Acid Multiplex Assay Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 8. Nucleic Acid Multiplex Assay Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 11. Global Nucleic Acid Multiplex Assay Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Nucleic Acid Multiplex Assay Revenue Market Share by Player (2019-2024)
Table 13. Nucleic Acid Multiplex Assay Key Players Head office and Products Offered
Table 14. Nucleic Acid Multiplex Assay Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic Acid Multiplex Assay Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Nucleic Acid Multiplex Assay Market Size Market Share by Regions (2019-2024)
Table 19. Global Nucleic Acid Multiplex Assay Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Nucleic Acid Multiplex Assay Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Nucleic Acid Multiplex Assay Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Country (2019-2024)
Table 23. Americas Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 25. Americas Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 27. APAC Nucleic Acid Multiplex Assay Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Table 29. APAC Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 31. APAC Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 33. Europe Nucleic Acid Multiplex Assay Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Country (2019-2024)
Table 35. Europe Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 37. Europe Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Nucleic Acid Multiplex Assay
Table 46. Key Market Challenges & Risks of Nucleic Acid Multiplex Assay
Table 47. Key Industry Trends of Nucleic Acid Multiplex Assay
Table 48. Global Nucleic Acid Multiplex Assay Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Nucleic Acid Multiplex Assay Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Nucleic Acid Multiplex Assay Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Luminex Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 53. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 54. Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Luminex Corporation (US) Main Business
Table 56. Luminex Corporation (US) Latest Developments
Table 57. Thermo Fisher Scientific Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 59. Thermo Fisher Scientific Inc. (US) Main Business
Table 60. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Scientific Inc. (US) Latest Developments
Table 62. Illumina, Inc (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 63. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Offered
Table 64. Illumina, Inc (US) Main Business
Table 65. Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Illumina, Inc (US) Latest Developments
Table 67. Bio-Rad Laboratories, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 68. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 69. Bio-Rad Laboratories, Inc. (US) Main Business
Table 70. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bio-Rad Laboratories, Inc. (US) Latest Developments
Table 72. Qiagen N.V. (Netherlands) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 73. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Offered
Table 74. Qiagen N.V. (Netherlands) Main Business
Table 75. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Qiagen N.V. (Netherlands) Latest Developments
Table 77. Abcam plc (UK) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 78. Abcam plc (UK) Nucleic Acid Multiplex Assay Product Offered
Table 79. Abcam plc (UK) Main Business
Table 80. Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Abcam plc (UK) Latest Developments
Table 82. Becton, Dickinson and Company (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 83. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Offered
Table 84. Becton, Dickinson and Company (US) Main Business
Table 85. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Becton, Dickinson and Company (US) Latest Developments
Table 87. Merck KGaA (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 88. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 89. Merck KGaA (Germany) Main Business
Table 90. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Merck KGaA (Germany) Latest Developments
Table 92. Agilent Technologies, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 93. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 94. Agilent Technologies, Inc. (US) Main Business
Table 95. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Agilent Technologies, Inc. (US) Latest Developments
Table 97. Meso Scale Diagnostics (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 98. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Offered
Table 99. Meso Scale Diagnostics (US) Main Business
Table 100. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Meso Scale Diagnostics (US) Latest Developments
Table 102. Randox Laboratories (UK) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 103. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Offered
Table 104. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Randox Laboratories (UK) Main Business
Table 106. Randox Laboratories (UK) Latest Developments
Table 107. Quanterix (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 108. Quanterix (US) Nucleic Acid Multiplex Assay Product Offered
Table 109. Quanterix (US) Main Business
Table 110. Quanterix (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Quanterix (US) Latest Developments
Table 112. Bio-Techne Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 113. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 114. Bio-Techne Corporation (US) Main Business
Table 115. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Bio-Techne Corporation (US) Latest Developments
Table 117. Olink (Sweden) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 118. Olink (Sweden) Nucleic Acid Multiplex Assay Product Offered
Table 119. Olink (Sweden) Main Business
Table 120. Olink (Sweden) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Olink (Sweden) Latest Developments
Table 122. DiaSorin S.p.A. (Italy) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 123. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Offered
Table 124. DiaSorin S.p.A. (Italy) Main Business
Table 125. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. DiaSorin S.p.A. (Italy) Latest Developments
Table 127. Seegene (South Korea) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 128. Seegene (South Korea) Nucleic Acid Multiplex Assay Product Offered
Table 129. Seegene (South Korea) Main Business
Table 130. Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Seegene (South Korea) Latest Developments
Table 132. Promega Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 133. Promega Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 134. Promega Corporation (US) Main Business
Table 135. Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Promega Corporation (US) Latest Developments
Table 137. Siemens Healthineers (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 138. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 139. Siemens Healthineers (Germany) Main Business
Table 140. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Siemens Healthineers (Germany) Latest Developments
Table 142. PerkinElmer, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 143. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 144. PerkinElmer, Inc. (US) Main Business
Table 145. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. PerkinElmer, Inc. (US) Latest Developments
Table 147. Shimadzu Biotech (Japan) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 148. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Offered
Table 149. Shimadzu Biotech (Japan) Main Business
Table 150. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Shimadzu Biotech (Japan) Latest Developments
Table 152. Antigenix America, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 153. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 154. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Antigenix America, Inc. (US) Main Business
Table 156. Antigenix America, Inc. (US) Latest Developments
Table 157. Enzo Life Sciences, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 158. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 159. Enzo Life Sciences, Inc. (US) Main Business
Table 160. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Enzo Life Sciences, Inc. (US) Latest Developments
Table 162. Boster Biological Technology (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 163. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Offered
Table 164. Boster Biological Technology (US) Main Business
Table 165. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. Boster Biological Technology (US) Latest Developments
Table 167. AYOXXA Biosystems GmbH (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 168. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 169. AYOXXA Biosystems GmbH (Germany) Main Business
Table 170. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. AYOXXA Biosystems GmbH (Germany) Latest Developments
Table 172. Cayman Chemical Company (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 173. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Offered
Table 174. Cayman Chemical Company (US) Main Business
Table 175. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Cayman Chemical Company (US) Latest Developments
Table 1. Nucleic Acid Multiplex Assay Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Planar Nucleic Acid Assays
Table 3. Major Players of Bead-Based Nucleic Acid Assays
Table 4. Major Players of Other Nucleic Acid Assays
Table 5. Nucleic Acid Multiplex Assay Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 8. Nucleic Acid Multiplex Assay Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 11. Global Nucleic Acid Multiplex Assay Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Nucleic Acid Multiplex Assay Revenue Market Share by Player (2019-2024)
Table 13. Nucleic Acid Multiplex Assay Key Players Head office and Products Offered
Table 14. Nucleic Acid Multiplex Assay Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic Acid Multiplex Assay Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Nucleic Acid Multiplex Assay Market Size Market Share by Regions (2019-2024)
Table 19. Global Nucleic Acid Multiplex Assay Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Nucleic Acid Multiplex Assay Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Nucleic Acid Multiplex Assay Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Country (2019-2024)
Table 23. Americas Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 25. Americas Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 27. APAC Nucleic Acid Multiplex Assay Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Table 29. APAC Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 31. APAC Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 33. Europe Nucleic Acid Multiplex Assay Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Country (2019-2024)
Table 35. Europe Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 37. Europe Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Nucleic Acid Multiplex Assay
Table 46. Key Market Challenges & Risks of Nucleic Acid Multiplex Assay
Table 47. Key Industry Trends of Nucleic Acid Multiplex Assay
Table 48. Global Nucleic Acid Multiplex Assay Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Nucleic Acid Multiplex Assay Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Nucleic Acid Multiplex Assay Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Luminex Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 53. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 54. Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Luminex Corporation (US) Main Business
Table 56. Luminex Corporation (US) Latest Developments
Table 57. Thermo Fisher Scientific Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 59. Thermo Fisher Scientific Inc. (US) Main Business
Table 60. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Scientific Inc. (US) Latest Developments
Table 62. Illumina, Inc (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 63. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product Offered
Table 64. Illumina, Inc (US) Main Business
Table 65. Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Illumina, Inc (US) Latest Developments
Table 67. Bio-Rad Laboratories, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 68. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 69. Bio-Rad Laboratories, Inc. (US) Main Business
Table 70. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bio-Rad Laboratories, Inc. (US) Latest Developments
Table 72. Qiagen N.V. (Netherlands) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 73. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product Offered
Table 74. Qiagen N.V. (Netherlands) Main Business
Table 75. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Qiagen N.V. (Netherlands) Latest Developments
Table 77. Abcam plc (UK) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 78. Abcam plc (UK) Nucleic Acid Multiplex Assay Product Offered
Table 79. Abcam plc (UK) Main Business
Table 80. Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Abcam plc (UK) Latest Developments
Table 82. Becton, Dickinson and Company (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 83. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product Offered
Table 84. Becton, Dickinson and Company (US) Main Business
Table 85. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Becton, Dickinson and Company (US) Latest Developments
Table 87. Merck KGaA (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 88. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 89. Merck KGaA (Germany) Main Business
Table 90. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Merck KGaA (Germany) Latest Developments
Table 92. Agilent Technologies, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 93. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 94. Agilent Technologies, Inc. (US) Main Business
Table 95. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Agilent Technologies, Inc. (US) Latest Developments
Table 97. Meso Scale Diagnostics (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 98. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product Offered
Table 99. Meso Scale Diagnostics (US) Main Business
Table 100. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Meso Scale Diagnostics (US) Latest Developments
Table 102. Randox Laboratories (UK) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 103. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product Offered
Table 104. Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Randox Laboratories (UK) Main Business
Table 106. Randox Laboratories (UK) Latest Developments
Table 107. Quanterix (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 108. Quanterix (US) Nucleic Acid Multiplex Assay Product Offered
Table 109. Quanterix (US) Main Business
Table 110. Quanterix (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Quanterix (US) Latest Developments
Table 112. Bio-Techne Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 113. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 114. Bio-Techne Corporation (US) Main Business
Table 115. Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Bio-Techne Corporation (US) Latest Developments
Table 117. Olink (Sweden) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 118. Olink (Sweden) Nucleic Acid Multiplex Assay Product Offered
Table 119. Olink (Sweden) Main Business
Table 120. Olink (Sweden) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Olink (Sweden) Latest Developments
Table 122. DiaSorin S.p.A. (Italy) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 123. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product Offered
Table 124. DiaSorin S.p.A. (Italy) Main Business
Table 125. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. DiaSorin S.p.A. (Italy) Latest Developments
Table 127. Seegene (South Korea) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 128. Seegene (South Korea) Nucleic Acid Multiplex Assay Product Offered
Table 129. Seegene (South Korea) Main Business
Table 130. Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Seegene (South Korea) Latest Developments
Table 132. Promega Corporation (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 133. Promega Corporation (US) Nucleic Acid Multiplex Assay Product Offered
Table 134. Promega Corporation (US) Main Business
Table 135. Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Promega Corporation (US) Latest Developments
Table 137. Siemens Healthineers (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 138. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 139. Siemens Healthineers (Germany) Main Business
Table 140. Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Siemens Healthineers (Germany) Latest Developments
Table 142. PerkinElmer, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 143. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 144. PerkinElmer, Inc. (US) Main Business
Table 145. PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. PerkinElmer, Inc. (US) Latest Developments
Table 147. Shimadzu Biotech (Japan) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 148. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product Offered
Table 149. Shimadzu Biotech (Japan) Main Business
Table 150. Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Shimadzu Biotech (Japan) Latest Developments
Table 152. Antigenix America, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 153. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 154. Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Antigenix America, Inc. (US) Main Business
Table 156. Antigenix America, Inc. (US) Latest Developments
Table 157. Enzo Life Sciences, Inc. (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 158. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product Offered
Table 159. Enzo Life Sciences, Inc. (US) Main Business
Table 160. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Enzo Life Sciences, Inc. (US) Latest Developments
Table 162. Boster Biological Technology (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 163. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product Offered
Table 164. Boster Biological Technology (US) Main Business
Table 165. Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. Boster Biological Technology (US) Latest Developments
Table 167. AYOXXA Biosystems GmbH (Germany) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 168. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product Offered
Table 169. AYOXXA Biosystems GmbH (Germany) Main Business
Table 170. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. AYOXXA Biosystems GmbH (Germany) Latest Developments
Table 172. Cayman Chemical Company (US) Details, Company Type, Nucleic Acid Multiplex Assay Area Served and Its Competitors
Table 173. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product Offered
Table 174. Cayman Chemical Company (US) Main Business
Table 175. Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Cayman Chemical Company (US) Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid Multiplex Assay Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Multiplex Assay Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nucleic Acid Multiplex Assay Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid Multiplex Assay Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid Multiplex Assay Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid Multiplex Assay Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid Multiplex Assay in Pharmaceutical & Biotechnology Companies
Figure 11. Global Nucleic Acid Multiplex Assay Market: Pharmaceutical & Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Nucleic Acid Multiplex Assay in Hospitals & Research Institutes
Figure 13. Global Nucleic Acid Multiplex Assay Market: Hospitals & Research Institutes (2019-2024) & ($ Millions)
Figure 14. Nucleic Acid Multiplex Assay in Reference Laboratories
Figure 15. Global Nucleic Acid Multiplex Assay Market: Reference Laboratories (2019-2024) & ($ Millions)
Figure 16. Nucleic Acid Multiplex Assay in Other
Figure 17. Global Nucleic Acid Multiplex Assay Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Nucleic Acid Multiplex Assay Market Size Market Share by Application in 2023
Figure 19. Global Nucleic Acid Multiplex Assay Revenue Market Share by Player in 2023
Figure 20. Global Nucleic Acid Multiplex Assay Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 22. APAC Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 23. Europe Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 25. Americas Nucleic Acid Multiplex Assay Value Market Share by Country in 2023
Figure 26. United States Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Region in 2023
Figure 31. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Type in 2023
Figure 32. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Application in 2023
Figure 33. China Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Country in 2023
Figure 40. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Figure 41. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Figure 42. Germany Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 56. APAC Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 57. Europe Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 59. United States Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 60. Canada Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 63. China Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 64. Japan Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 65. Korea Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 67. India Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 68. Australia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 69. Germany Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 70. France Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 71. UK Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 72. Italy Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 73. Russia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 74. Spain Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 77. Israel Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 80. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Nucleic Acid Multiplex Assay Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Multiplex Assay Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nucleic Acid Multiplex Assay Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nucleic Acid Multiplex Assay Sales Market Share by Country/Region (2023)
Figure 8. Nucleic Acid Multiplex Assay Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nucleic Acid Multiplex Assay Market Size Market Share by Type in 2023
Figure 10. Nucleic Acid Multiplex Assay in Pharmaceutical & Biotechnology Companies
Figure 11. Global Nucleic Acid Multiplex Assay Market: Pharmaceutical & Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Nucleic Acid Multiplex Assay in Hospitals & Research Institutes
Figure 13. Global Nucleic Acid Multiplex Assay Market: Hospitals & Research Institutes (2019-2024) & ($ Millions)
Figure 14. Nucleic Acid Multiplex Assay in Reference Laboratories
Figure 15. Global Nucleic Acid Multiplex Assay Market: Reference Laboratories (2019-2024) & ($ Millions)
Figure 16. Nucleic Acid Multiplex Assay in Other
Figure 17. Global Nucleic Acid Multiplex Assay Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Nucleic Acid Multiplex Assay Market Size Market Share by Application in 2023
Figure 19. Global Nucleic Acid Multiplex Assay Revenue Market Share by Player in 2023
Figure 20. Global Nucleic Acid Multiplex Assay Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 22. APAC Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 23. Europe Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Nucleic Acid Multiplex Assay Market Size 2019-2024 ($ Millions)
Figure 25. Americas Nucleic Acid Multiplex Assay Value Market Share by Country in 2023
Figure 26. United States Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Region in 2023
Figure 31. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Type in 2023
Figure 32. APAC Nucleic Acid Multiplex Assay Market Size Market Share by Application in 2023
Figure 33. China Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Country in 2023
Figure 40. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Figure 41. Europe Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Figure 42. Germany Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Nucleic Acid Multiplex Assay Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Nucleic Acid Multiplex Assay Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 56. APAC Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 57. Europe Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 59. United States Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 60. Canada Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 63. China Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 64. Japan Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 65. Korea Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 67. India Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 68. Australia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 69. Germany Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 70. France Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 71. UK Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 72. Italy Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 73. Russia Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 74. Spain Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 77. Israel Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Nucleic Acid Multiplex Assay Market Size 2025-2030 ($ Millions)
Figure 80. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Nucleic Acid Multiplex Assay Market Size Market Share Forecast by Application (2025-2030)
